
Suvemcitug Injection Approval in China丨Brings a New Treatment Option for Platinum-Resistant Ovarian Cancer
On July 3, 2025, Simcere Pharmaceutical Group Limited’s innovative drug subsidiary, Simcere, announced that its…

On July 3, 2025, Simcere Pharmaceutical Group Limited’s innovative drug subsidiary, Simcere, announced that its…

Recently, the National Medical Products Administration (NMPA) granted conditional approval for Olgotrelvir Sodium Capsules, a…

The National Medical Products Administration (NMPA) has officially approved Firsekibart Injection, a Class 1 innovative…

With the rapid globalization of China’s pharmaceutical industry, the question of how China ensures the…

For international importers and healthcare distributors, learning how to verify authenticity of Chinese medicines has…

Nanjing Zenshine Pharmaceutical Co., Ltd. has announced that its independently developed antiviral drug, Sebaloxavir Marboxil…

Suzhou Ascentage Pharma has achieved a significant milestone with the conditional approval of Lisaftoclax Tablets…

The National Medical Products Administration (NMPA) of China has granted conditional approval for Ifupinostat Hydrochloride…

The National Medical Products Administration (NMPA) has officially approved Zeprumetostat Tablets (brand name: Airuijing, development…

As Artificial Intelligence (AI) continues to evolve, the global pharmaceutical industry is undergoing a profound…